Evidence map›Paper›PMID 39289358›Full record

ArticleNature communications2024

Claustrum and dorsal endopiriform cortex complex cell-identity is determined by Nurr1 and regulates hallucinogenic-like states in mice.

Ioannis Mantas, Ivana Flais, Yuvarani Masarapu, Tudor Ionescu, Solène Frapard, Felix Jung, Pierre Le Merre, Marcus Saarinen, Katarina Tiklova, Behzad Yaghmaeian Salmani and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Nurr1 Orchestrates Claustrum Development and Functionality.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ioannis MantasDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. ioannis.mantas@ki.se.ORCID 0000-0001-6288-5439
Ivana FlaisDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Yuvarani MasarapuScience for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID 0000-0002-3267-2085
Tudor IonescuCNSDR, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Solène FrapardScience for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID 0000-0002-2649-7225
Felix JungDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Pierre Le MerreDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-4205-7411
Marcus SaarinenDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Katarina TiklovaDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Behzad Yaghmaeian SalmaniDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-4221-6243
Linda GillbergDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Xiaoqun ZhangDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9461-8682
Karima CherguiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Marie CarlénDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-1658-1631
Stefania GiacomelloScience for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Stockholm, Sweden.ORCID 0000-0003-0738-1574
Bastian HengererCNSDR, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.ORCID 0000-0002-7811-9795
Thomas PerlmannDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.
Per SvenningssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6727-3802

Funding

Vetenskapsrådet (Swedish Research Council) 2019-01422
6 · The paper itself

Abstract

The Claustrum/dorsal endopiriform cortex complex (CLA) is an enigmatic brain region with extensive glutamatergic projections to multiple cortical areas. The transcription factor Nurr1 is highly expressed in the CLA, but its role in this region is not understood. By using conditional gene-targeted mice, we show that Nurr1 is a crucial regulator of CLA neuron identity. Although CLA neurons remain intact in the absence of Nurr1, the distinctive gene expression pattern in the CLA is abolished. CLA has been hypothesized to control hallucinations, but little is known of how the CLA responds to hallucinogens. After the deletion of Nurr1 in the CLA, both hallucinogen receptor expression and signaling are lost. Furthermore, functional ultrasound and Neuropixel electrophysiological recordings revealed that the hallucinogenic-receptor agonists' effects on functional connectivity between prefrontal and sensorimotor cortices are altered in Nurr1-ablated mice. Our findings suggest that Nurr1-targeted strategies provide additional avenues for functional studies of the CLA.

Indexed as

ClaustrumHallucinogensNeuronsNuclear Receptor Subfamily 4, Group A, Member 2AnimalsMaleMiceMice, Inbred C57BLMice, KnockoutPrefrontal CortexSensorimotor CortexHallucinogensNr4a2 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 2

Identifiers

PMID39289358
PMCPMC11408527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.